Salix Announces 2022 Gastrointestinal Health Scholars Program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St hits two-week lows as rising bond yields, Walmart results drag
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
RBC Capital Sees Positive Read-Through to Bausch Health Companies (BHC) from Alcon's (ALC) EPS
February 16, 2022 10:15 AM ESTRBC Capital analyst Doug Miehm reiterated an Outperform rating and $34.00 price target on Bausch Health Companies (NYSE: BHC).
The analyst comments "Alcon reported strong Q4/21 results with revenues at $2.13B (+10.9% y/y) ahead of consensus($2.10B). Surgical segment revenues grew... More
